These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 20532175)

  • 1. Modeling the time evolution of the nanoparticle-protein corona in a body fluid.
    Dell'Orco D; Lundqvist M; Oslakovic C; Cedervall T; Linse S
    PLoS One; 2010 Jun; 5(6):e10949. PubMed ID: 20532175
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Understanding the nanoparticle-protein corona using methods to quantify exchange rates and affinities of proteins for nanoparticles.
    Cedervall T; Lynch I; Lindman S; Berggård T; Thulin E; Nilsson H; Dawson KA; Linse S
    Proc Natl Acad Sci U S A; 2007 Feb; 104(7):2050-5. PubMed ID: 17267609
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dynamics of nanoparticle-protein corona complex formation: analytical results from population balance equations.
    Darabi Sahneh F; Scoglio C; Riviere J
    PLoS One; 2013; 8(5):e64690. PubMed ID: 23741371
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Understanding the Kinetics of Protein-Nanoparticle Corona Formation.
    Vilanova O; Mittag JJ; Kelly PM; Milani S; Dawson KA; Rädler JO; Franzese G
    ACS Nano; 2016 Dec; 10(12):10842-10850. PubMed ID: 28024351
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Plasma proteins facilitates placental transfer of polystyrene particles.
    Gruber MM; Hirschmugl B; Berger N; Holter M; Radulović S; Leitinger G; Liesinger L; Berghold A; Roblegg E; Birner-Gruenberger R; Bjelic-Radisic V; Wadsack C
    J Nanobiotechnology; 2020 Sep; 18(1):128. PubMed ID: 32907583
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nanomedicine delivery: does protein corona route to the target or off road?
    Maiolo D; Del Pino P; Metrangolo P; Parak WJ; Baldelli Bombelli F
    Nanomedicine (Lond); 2015; 10(21):3231-47. PubMed ID: 26470748
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Protein-nanoparticle interactions and a new insight.
    Ghosh G; Panicker L
    Soft Matter; 2021 Apr; 17(14):3855-3875. PubMed ID: 33885450
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The evolution of the protein corona around nanoparticles: a test study.
    Lundqvist M; Stigler J; Cedervall T; Berggård T; Flanagan MB; Lynch I; Elia G; Dawson K
    ACS Nano; 2011 Sep; 5(9):7503-9. PubMed ID: 21861491
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Corona Composition Can Affect the Mechanisms Cells Use to Internalize Nanoparticles.
    Francia V; Yang K; Deville S; Reker-Smit C; Nelissen I; Salvati A
    ACS Nano; 2019 Oct; 13(10):11107-11121. PubMed ID: 31525954
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum type and concentration both affect the protein-corona composition of PLGA nanoparticles.
    Partikel K; Korte R; Mulac D; Humpf HU; Langer K
    Beilstein J Nanotechnol; 2019; 10():1002-1015. PubMed ID: 31165027
    [No Abstract]   [Full Text] [Related]  

  • 11. Nanoparticle-protein complexes mimicking corona formation in ocular environment.
    Jo DH; Kim JH; Son JG; Dan KS; Song SH; Lee TG; Kim JH
    Biomaterials; 2016 Dec; 109():23-31. PubMed ID: 27648757
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Complete high-density lipoproteins in nanoparticle corona.
    Hellstrand E; Lynch I; Andersson A; Drakenberg T; Dahlbäck B; Dawson KA; Linse S; Cedervall T
    FEBS J; 2009 Jun; 276(12):3372-81. PubMed ID: 19438706
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Protein Nanoparticle Charge and Hydrophobicity Govern Protein Corona and Macrophage Uptake.
    Pustulka SM; Ling K; Pish SL; Champion JA
    ACS Appl Mater Interfaces; 2020 Oct; 12(43):48284-48295. PubMed ID: 33054178
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Simple spectroscopic determination of the hard protein corona composition in AuNPs: albumin at 75.
    Vitali M; Casals E; Canals F; Colomé N; Puntes V
    Nanoscale; 2020 Aug; 12(29):15832-15844. PubMed ID: 32692793
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Formation of the Protein Corona: The Interface between Nanoparticles and the Immune System.
    Barbero F; Russo L; Vitali M; Piella J; Salvo I; Borrajo ML; Busquets-Fité M; Grandori R; Bastús NG; Casals E; Puntes V
    Semin Immunol; 2017 Dec; 34():52-60. PubMed ID: 29066063
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Technical tip: high-resolution isolation of nanoparticle-protein corona complexes from physiological fluids.
    Di Silvio D; Rigby N; Bajka B; Mayes A; Mackie A; Baldelli Bombelli F
    Nanoscale; 2015 Jul; 7(28):11980-90. PubMed ID: 26108682
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Time evolution of nanoparticle-protein corona in human plasma: relevance for targeted drug delivery.
    Barrán-Berdón AL; Pozzi D; Caracciolo G; Capriotti AL; Caruso G; Cavaliere C; Riccioli A; Palchetti S; Laganà A
    Langmuir; 2013 May; 29(21):6485-94. PubMed ID: 23631648
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Modeling of a single nanoparticle interaction with the human blood plasma proteins.
    Skakauskas V; Katauskis P
    J Biol Phys; 2018 Dec; 44(4):605-617. PubMed ID: 30209704
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Crown and the Scepter: Roles of the Protein Corona in Nanomedicine.
    Cai R; Chen C
    Adv Mater; 2019 Nov; 31(45):e1805740. PubMed ID: 30589115
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular Modeling of Protein Corona Formation and Its Interactions with Nanoparticles and Cell Membranes for Nanomedicine Applications.
    Lee H
    Pharmaceutics; 2021 Apr; 13(5):. PubMed ID: 33947090
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.